Good afternoon :)
Place Order
Add to Watchlist

Advanced Enzyme Technologies Ltd

ADVENZYMES

Advanced Enzyme Technologies Ltd

ADVENZYMES
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹3,964 cr, stock is ranked 743
High RiskStock is 3.12x as volatile as Nifty
350.501.14% (-4.05)
350.501.14% (-4.05)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹3,964 cr, stock is ranked 743
High RiskStock is 3.12x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹3,964 cr, stock is ranked 743
High RiskStock is 3.12x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
28.913.090.28%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
25.143.252.75%

Forecast & Ratings

Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Advanced Enzyme Technologies is engaged in the research and development, manufacturing and marketing of over 400 products developed from over 60 indigenous enzymes.

Investor Presentation

View older 

Aug 12, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 7.6%, vs industry avg of 9.57%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.78% to 0.61%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 3.24%, vs industry avg of 18.3%

Loading...

Financial YearFY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023TTM
Total Revenue223.27295.05331.57392.41424.63449.63510.69535.80566.10643.01
Raw Materialssubtract47.9969.6670.1480.3365.9590.83100.21130.32127.53415.59
Power & Fuel Costsubtract10.1310.1712.8718.1019.2919.3721.4529.9538.10
Employee Costsubtract36.1044.5050.7068.6080.2380.1987.11103.96114.80
Selling & Administrative Expensessubtract23.9123.5025.6138.4140.0437.5837.7251.8056.22
Operating & Other expensessubtract13.1212.4718.0020.6430.8412.6522.7810.7750.56
Depreciation/Amortizationsubtract9.028.7212.7618.3021.1225.7828.7234.9835.0334.41
Interest & Other Itemssubtract9.267.864.439.065.204.082.572.963.482.69
Taxes & Other Itemssubtract23.6542.3445.5148.9150.9049.8764.2151.4834.7553.20
EPS0.921.392.798.079.9511.5813.0610.709.4512.26
DPS0.170.200.080.500.600.600.901.001.005.00
Payout ratio0.180.140.030.060.060.050.070.090.110.41

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 20PDF
Feb 5PDF
Nov 2PDF
+2 more
FY 2023

Annual report

PDF

Investor Presentation

May 13PDF
Feb 11PDF
Nov 11PDF
Aug 6PDF
FY 2024

Annual Report Pending

Investor Presentation

Aug 12PDF
 

Peers & Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Advanced Enzyme Technologies Ltd37.533.090.28%
Gujarat Fluorochemicals Ltd25.676.180.13%
Aarti Industries Ltd43.764.850.38%
Vinati Organics Ltd34.037.030.46%

Price Comparison

Compare ADVENZYMES with any stock or ETF
Compare ADVENZYMES with any stock or ETF
ADVENZYMES
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 2.90%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.24%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding43.62%5.42%1.57%22.54%26.86%

Mar 2023

Jun 2023

Sep 2023

Dec 2023

Shareholding History

SepDec '22MarJunSepDec '2321.68%21.74%21.86%21.90%22.27%22.54%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Advanced Enzyme Technologies Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
HDFC Small Cap Fund - Direct Plan - Growth Option

Growth
3.1256%0.43%0.02%68/78 (+5)
ICICI Prudential ESG Exclusionary Strategy Fund - Growth - Direct Plan

Growth
0.9573%2.67%0.18%12/57 (0)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth

Growth
0.8046%0.89%0.03%37/50 (-5)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ADVENZYMES has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.28%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.82 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 4, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Aug 4, 2023

Cash Dividend

Ex DateEx DateMay 19, 2023

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

May 19, 2023

Cash Dividend

Ex DateEx DateAug 11, 2022

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Aug 11, 2022

Cash Dividend

Ex DateEx DateAug 31, 2021

Final
Final | Div/Share: ₹0.90

Dividend/Share

0.90

Ex DateEx Date

Aug 31, 2021

Cash Dividend

Ex DateEx DateJul 9, 2020

Final
Final | Div/Share: ₹0.60

Dividend/Share

0.60

Ex DateEx Date

Jul 9, 2020